DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 1Aurobindo Pharma Limited
03 1DARMERICA, LLC
04 2F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
05 1Formosa Laboratories, Inc.
06 1Hetero Labs Limited
07 1Hubei Biocause Heilen Pharmaceutical Co., Ltd
08 1LAURUS LABS LIMITED
09 1Laurus Labs Limited
10 2MSN Laboratories Private Limited
11 1Natco Pharma Limited
12 1Pliva Hrvatska d.o.o.
13 2SHILPA PHARMA LIFESCIENCES LIMITED
14 1SUN PHARMACEUTICAL INDUSTRIES, INC.
15 1Sterling Pharma Solutions Limited
16 1TAPI Croatia Industries Ltd.
17 1Valary Lab Private Limited
18 1zhejiang jiuzhou pharmaceutical Co., Ltd.
01 1IMATINIB
02 1IMATINIB BASE
03 1IMATINIB MESILATE
04 1IMATINIB MESYLATE
05 2Imatinib
06 11Imatinib Mesylate
07 1Imatinib Mesylate (IMA)
08 1Imatinib Mesylate (IMN)
09 2Imatinib mesylate
01 2China
02 1Croatia
03 11India
04 2Italy
05 1Taiwan
06 1U.S.A
07 1United Kingdom
08 2Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-939
Start Marketing Date : 2011-03-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0121
Start Marketing Date : 2018-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0143
Start Marketing Date : 2018-12-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42385-316
Start Marketing Date : 2013-05-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42385-720
Start Marketing Date : 2013-05-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0005
Start Marketing Date : 2011-10-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0066
Start Marketing Date : 2017-12-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11722-080
Start Marketing Date : 2024-05-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50384-6200
Start Marketing Date : 2023-07-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (640kg/640kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11722-052
Start Marketing Date : 2011-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Imatinib Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imatinib Mesylate, including repackagers and relabelers. The FDA regulates Imatinib Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imatinib Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imatinib Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imatinib Mesylate supplier is an individual or a company that provides Imatinib Mesylate active pharmaceutical ingredient (API) or Imatinib Mesylate finished formulations upon request. The Imatinib Mesylate suppliers may include Imatinib Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Imatinib Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Imatinib Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Imatinib Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Imatinib Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Imatinib Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Imatinib Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Imatinib Mesylate suppliers with NDC on PharmaCompass.
We have 15 companies offering Imatinib Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
